Zhanyu Pan

机构：Tianjin University, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University · ORCID：0000-0002-8447-0119

发表论文 26 篇 · 总被引 421 次 · h-index 10

代表论文

• Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune (2017 · Biomedicine & Pharmacotherapy · 被引 141)
• Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization (2022 · Phytomedicine · 被引 59)
• Rhamnetin induces apoptosis in human breast cancer cells via the miR‑34a/Notch‑1 signaling pathway (2018 · Oncology Letters · 被引 46)
• Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial (2017 · Integrative Cancer Therapies · 被引 35)
• Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines. (2015 · PubMed · 被引 27)
• The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial (2025 · Nature Medicine · 被引 22)